Clinical Trial Update: Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]

View source ↗

Summary

The safety and efficacy study of DE-104 ophthalmic solution for open-angle glaucoma or ocular hypertension has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DE-104 ophthalmic solution (DE-104)

Snippet

Sponsor: Santen Inc. | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 1, Phase 2 | Status: COMPLETED